<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>04250311909493</udiDi>
    <basicUdiDi>42503119SOHY-F-OPHTHA7K</basicUdiDi>
    <tradeName>HiMed 3.0%</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Albomed GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000007875</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>04580</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-06-17T11:28:17.879Z</lastUpdated>
  </row>
  <row>
    <udiDi>04250311909486</udiDi>
    <basicUdiDi>42503119SOHY-F-OPHTHA7K</basicUdiDi>
    <tradeName>HiMed 1.6%</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Albomed GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000007875</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>00169</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-06-17T11:28:16.966Z</lastUpdated>
  </row>
  <row>
    <udiDi>04250311909479</udiDi>
    <basicUdiDi>42503119SOHY-F-OPHTHA7K</basicUdiDi>
    <tradeName>HiMed 1.4%</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Albomed GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000007875</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>00166</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-06-17T11:28:16.065Z</lastUpdated>
  </row>
  <row>
    <udiDi>04250311909349</udiDi>
    <basicUdiDi>42503119SOHY-F-OPHTHA7K</basicUdiDi>
    <tradeName>an-bfh 2.2%</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Albomed GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000007875</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>03360</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-06-17T11:28:13.372Z</lastUpdated>
  </row>
  <row>
    <udiDi>04250311909332</udiDi>
    <basicUdiDi>42503119SOHY-F-OPHTHA7K</basicUdiDi>
    <tradeName>an-bfh 1.8%</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Albomed GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000007875</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>03359</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-06-17T11:28:12.462Z</lastUpdated>
  </row>
  <row>
    <udiDi>04250311909202</udiDi>
    <basicUdiDi>42503119SOHY-F-OPHTHA7K</basicUdiDi>
    <tradeName>i-Visc 3.0%</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Albomed GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000007875</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>04527</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-06-17T11:28:08.872Z</lastUpdated>
  </row>
  <row>
    <udiDi>04250311909196</udiDi>
    <basicUdiDi>42503119SOHY-F-OPHTHA7K</basicUdiDi>
    <tradeName>i-Visc 1.8%</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Albomed GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000007875</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>04524</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-06-17T11:28:07.967Z</lastUpdated>
  </row>
  <row>
    <udiDi>04250311909172</udiDi>
    <basicUdiDi>42503119SOHY-F-OPHTHA7K</basicUdiDi>
    <tradeName>i-Visc 1.4%</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Albomed GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000007875</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>04522</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-06-17T11:28:00.945Z</lastUpdated>
  </row>
  <row>
    <udiDi>04250311909165</udiDi>
    <basicUdiDi>42503119SOHY-F-OPHTHA7K</basicUdiDi>
    <tradeName>i-Visc 1.0%</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Albomed GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000007875</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>04521</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-06-17T11:28:00.093Z</lastUpdated>
  </row>
  <row>
    <udiDi>04250311909134</udiDi>
    <basicUdiDi>42503119SOHY-F-OPHTHA7K</basicUdiDi>
    <tradeName>EasyLuron 3.0%</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Albomed GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000007875</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>04504</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-06-17T11:27:59.153Z</lastUpdated>
  </row>
  <row>
    <udiDi>04250311909127</udiDi>
    <basicUdiDi>42503119SOHY-F-OPHTHA7K</basicUdiDi>
    <tradeName>EasyLuron 1.8%</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Albomed GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000007875</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>04503</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-06-17T11:27:58.258Z</lastUpdated>
  </row>
  <row>
    <udiDi>04250311909110</udiDi>
    <basicUdiDi>42503119SOHY-F-OPHTHA7K</basicUdiDi>
    <tradeName>EasyLuron 1.6%</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Albomed GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000007875</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>04502</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-06-17T11:27:57.355Z</lastUpdated>
  </row>
  <row>
    <udiDi>04250311909103</udiDi>
    <basicUdiDi>42503119SOHY-F-OPHTHA7K</basicUdiDi>
    <tradeName>EasyLuron 1.4%</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Albomed GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000007875</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>04501</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-06-17T11:27:56.460Z</lastUpdated>
  </row>
  <row>
    <udiDi>04250311909097</udiDi>
    <basicUdiDi>42503119SOHY-F-OPHTHA7K</basicUdiDi>
    <tradeName>EasyLuron 1.0%</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Albomed GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000007875</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>04500</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-06-17T11:27:55.561Z</lastUpdated>
  </row>
  <row>
    <udiDi>04250311909080</udiDi>
    <basicUdiDi>42503119SOHY-F-OPHTHA7K</basicUdiDi>
    <tradeName>Pe-Ha-Luron F 2.2%</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Albomed GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000007875</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>04490</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-06-17T11:27:54.653Z</lastUpdated>
  </row>
  <row>
    <udiDi>04250311909073</udiDi>
    <basicUdiDi>42503119SOHY-F-OPHTHA7K</basicUdiDi>
    <tradeName>Viscophta 100</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Albomed GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000007875</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>00421</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-06-17T11:27:53.754Z</lastUpdated>
  </row>
  <row>
    <udiDi>04250311908878</udiDi>
    <basicUdiDi>42503119SOHY-F-OPHTHA7K</basicUdiDi>
    <tradeName>Pe-Ha-Luron F 3.0%</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Albomed GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000007875</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>04424</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-06-17T11:27:51.944Z</lastUpdated>
  </row>
  <row>
    <udiDi>04250311908861</udiDi>
    <basicUdiDi>42503119SOHY-F-OPHTHA7K</basicUdiDi>
    <tradeName>Pe-Ha-Luron F 1.8%</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Albomed GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000007875</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>04423</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-06-17T11:27:51.048Z</lastUpdated>
  </row>
  <row>
    <udiDi>04250311908854</udiDi>
    <basicUdiDi>42503119SOHY-F-OPHTHA7K</basicUdiDi>
    <tradeName>Pe-Ha-Luron F 1.6%</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Albomed GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000007875</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>04422</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-06-17T11:27:50.146Z</lastUpdated>
  </row>
  <row>
    <udiDi>04250311908847</udiDi>
    <basicUdiDi>42503119SOHY-F-OPHTHA7K</basicUdiDi>
    <tradeName>Pe-Ha-Luron F 1.4%</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Albomed GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000007875</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>04421</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-06-17T11:27:49.242Z</lastUpdated>
  </row>
</eudamedExport>